A novel, long-acting glucagon-like peptide receptor-agonist: dulaglutide

A novel, long-acting glucagon-like peptide receptor-agonist: dulaglutide

Tara Gurung,1 Deepson S Shyangdan,1 Joseph Paul O’Hare,2 Norman Waugh1 1Warwick Evidence, 2Division of Metabolic and Vascular Health, Warwick Medical School, University of Warwick, Coventry, UK Background: Dulaglutide is a new, long-acting glucagon-like peptide analogue in the treatment of...

Full description

Bibliographic Details
Main Authors: Gurung T, Shyangdan DS, O’Hare JP, Waugh N
Format: Article
Language:English
Published: Dove Medical Press 2015-08-01
Series:Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy
Online Access:http://www.dovepress.com/a-novel-long-acting-glucagon-like-peptide-receptor-agonist-dulaglutide-peer-reviewed-article-DMSO

Internet

http://www.dovepress.com/a-novel-long-acting-glucagon-like-peptide-receptor-agonist-dulaglutide-peer-reviewed-article-DMSO

Similar Items